Uroplasty (Minneapolis) reported plans to double its U.S. sales force by the end of FY09, which began on April 1.
"We have successfully launched our second-generation Urgent PC neuromodulation system in the U.S. and in fiscal 2008 built a domestic sales force that has generated significant year-to-date sales growth," said David Kaysen, president/CEO. "As a result of this strong performance, and with the opportunity to continue our revenue growth during fiscal 2009, we plan to double the number of U.S. sales representatives to 36 from a team of 18 employed as of March 31, 2008."
The Urgent PC neuromodulation system is a minimally invasive nerve stimulation device designed for office-based treatment of OAB symptoms of urge incontinence, urinary urgency and urinary frequency. Application of neuromodulation therapy targets specific nerve tissue and disrupts the signals that lead to the symptoms of OAB.